Patient
P2B-008
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Healthcare Institution "Republican Clinical Oncological Center of the Ministry of Health of Republic of Tatarstan" (Kazan', Russia) (Dr. Clarke)
consented 2012-05-25
Adverse events
0
Serious AEs
0
Open data queries
2
Luna dropout signal
—
not on Luna
Adverse events 0
No adverse events recorded
Events reported by the site or through Luna appear here.
Data queries 2
Visit Cycle 6 Day 1: infusion (last planned cycle) (V7) for P2B-008 occurred on 2012-10-01, 12 d late against planned day 106 (2012-09-19 ± 3 d, anchored on first dose 2012-06-06). Confirm the visit date or record a protocol deviation.
Visit Cycle 5 Day 1: infusion; week-12 CT/MRI and ECHO/MUGA before dosing (V6) for P2B-008 occurred on 2012-09-11, 13 d late against planned day 85 (2012-08-29 ± 3 d, anchored on first dose 2012-06-06). Confirm the visit date or record a protocol deviation.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.